EFIENT

This brand name is authorized in Austria, Cyprus, Estonia, Finland, France, Germany, Ireland, Italy, Japan, Lithuania, Netherlands, Poland, Romania, South Africa, Spain, Tunisia, UK.

Active ingredients

The drug EFIENT contains one active pharmaceutical ingredient (API):

1	Prasugrel UNII G89JQ59I13 - PRASUGREL HYDROCHLORIDE
	Prasugrel is an inhibitor of platelet activation and aggregation through the irreversible binding of its active metabolite to the P2Y12 class of ADP receptors on platelets. Since platelets participate in the initiation and/or evolution of thrombotic complications of atherosclerotic disease, inhibition of platelet function can result in the reduction of the rate of cardiovascular events such as death, myocardial infarction, or stroke.
	Read more about Prasugrel

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EFIENT Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AC22	Prasugrel	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC22

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	05386702, 05743527, 05871834, 05906484, 06562414, 06568693, 06568701, 07580526, 07668273, 07745186, 07745192, 09188844, 09188867, 09188896, 09188910, 09276198, 09276206, 09902365, 10535914, 11309634, 11861610, 12505840, 12505857, 12593198, 12652328, 12652340, 14266322, 14266339, 14355994, 16354668, 16768619, 17390123, 17541042
EE	Ravimiamet	1412862, 1412941, 1412963, 1412974, 1412985, 1412996, 1413009, 1413010, 1413021, 1413032, 1413043, 1413054, 1413065, 1413076
ES	Centro de información online de medicamentos de la AEMPS	08503002, 08503009, 08503013
FI	Lääkealan turvallisuus- ja kehittämiskeskus	034468, 034479
FR	Base de données publique des médicaments	65916489
GB	Medicines & Healthcare Products Regulatory Agency	152403, 152412, 374349, 374414, 381317, 386063
IE	Health Products Regulatory Authority	13741, 13809, 13856, 27007
IT	Agenzia del Farmaco	039055025, 039055090
JP	医薬品医療機器総合機構	3399009F1020, 3399009F2026, 3399009F3022, 3399009F5025
LT	Valstybinė vaistų kontrolės tarnyba	1036507, 1036508, 1036509, 1036510, 1036511, 1036512, 1036513, 1036514, 1036515, 1036516, 1036517, 1036518, 1036519, 1036520, 1063748, 1063749
NL	Z-Index G-Standaard, PRK	90530, 90549
PL	Rejestru Produktów Leczniczych	100206170, 100206187
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W62438001, W62438002, W62438003, W62438004, W62438005, W62438006, W62438007, W62439001, W62439002, W62439003, W62439004, W62439005, W62439006, W62439007
TN	Direction de la Pharmacie et du Médicament	12073011, 12073012
ZA	Health Products Regulatory Authority	43/8.2/0242, 43/8.2/0243